Shares of Medidata Solutions Inc. (NASDAQ:MDSO) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $55.36 and last traded at $54.99, with a volume of 163,463 shares changing hands. The stock had previously closed at $53.77.

A number of analysts have recently issued reports on MDSO shares. Morgan Stanley reiterated a “buy” rating on shares of Medidata Solutions in a research report on Friday, June 10th. Needham & Company LLC reiterated a “buy” rating and set a $60.00 price target (up previously from $55.00) on shares of Medidata Solutions in a research report on Sunday, July 24th. Zacks Investment Research upgraded Medidata Solutions from a “hold” rating to a “buy” rating and set a $51.00 price target for the company in a research report on Friday, April 29th. Leerink Swann reiterated a “market perform” rating on shares of Medidata Solutions in a research report on Monday, April 25th. Finally, KeyCorp reiterated a “buy” rating on shares of Medidata Solutions in a research report on Thursday, July 7th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the stock. Medidata Solutions has a consensus rating of “Buy” and a consensus price target of $51.70.

The company has a 50-day moving average price of $51.57 and a 200 day moving average price of $43.46. The company has a market cap of $3.06 billion and a price-to-earnings ratio of 141.77.

Medidata Solutions (NASDAQ:MDSO) last issued its quarterly earnings results on Wednesday, July 20th. The company reported $0.24 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. During the same quarter in the previous year, the company earned $0.22 EPS. The company earned $114.60 million during the quarter, compared to analysts’ expectations of $112.39 million. The business’s quarterly revenue was up 16.8% compared to the same quarter last year. Equities analysts predict that Medidata Solutions Inc. will post $1.01 earnings per share for the current fiscal year.

In other Medidata Solutions news, EVP Eileen Schloss sold 10,644 shares of the company’s stock in a transaction dated Tuesday, July 26th. The stock was sold at an average price of $52.82, for a total value of $562,216.08. Following the completion of the sale, the executive vice president now owns 25,765 shares in the company, valued at $1,360,907.30. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, President Vries Glen Michael De sold 7,500 shares of the company’s stock in a transaction dated Tuesday, August 9th. The stock was sold at an average price of $54.39, for a total value of $407,925.00. Following the completion of the sale, the president now owns 982,653 shares of the company’s stock, valued at approximately $53,446,496.67. The disclosure for this sale can be found here.

A hedge fund recently raised its stake in Medidata Solutions stock. Bank of Montreal Can increased its position in Medidata Solutions Inc. (NASDAQ:MDSO) by 96.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 33,760 shares of the company’s stock after buying an additional 16,587 shares during the period. Bank of Montreal Can owned approximately 0.06% of Medidata Solutions worth $1,664,000 at the end of the most recent reporting period.

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Medidata Clinical Cloud provides a platform of technology and data analytics solutions designed to manage activities across clinical development.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.